Skip to content
lifestyle.ideacrossing.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nxera Pharma
Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
April 29, 2026
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
March 31, 2026
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
March 5, 2026
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
March 4, 2026
Nxera Pharma Proposes Changes to its Board of Directors
February 14, 2026
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
February 14, 2026
Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals
February 13, 2026
Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company
February 13, 2026
Nxera Pharma Webinar Presentation for FY2025 Financial Results
January 26, 2026
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
January 20, 2026
←
Previous Page
1
2
3
Next Page
→